In summary, Bodén et al. concluded that the observed lower striatal PDE10A expression in patients with schizophrenia has to be verified, preferably in longitudinal studies of treated and untreated patients with early disease stages to elucidate whether this is a pathophysiological feature or an effect of antipsychotic treatment [161]. The gene discussed is PDE10A; the disease is schizophrenia.